In an analysis of UK clinical cases, the stx2a subtype was also shown to be a pre-requisite for the development of HUS, and in vitro assays have shown that Stx2a is 1000 times more toxic than the Stx1 variant to human renal cells [3,36]. This evidence concerns the gene STX2 and hemolytic-uremic syndrome.